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Abstract
Background and Objective: The NeuroFlexor is a novel instrument for quantification of neural, viscous and elastic
components of passive movement resistance. The aim of this study was to provide normative data and cut-off
values from healthy subjects and to use these to explore signs of spasticity at the wrist and fingers in patients
recovering from stroke.
Methods: 107 healthy subjects (age range 28–68 years; 51 % females) and 39 stroke patients (age range 33–69 years;
33 % females), 2–4 weeks after stroke, were assessed with the NeuroFlexor. Cut-off values based on mean + 3SD of the
reference data were calculated. In patients, the modified Ashworth scale (MAS) was also applied.
Results: In healthy subjects, neural component was 0.8 ± 0.9 N (mean ± SD), elastic component was 2.7 ± 1.1 N, viscous
component was 0.3 ± 0.3 N and resting tension was 5.9 ± 1 N. Age only correlated with elastic component (r = −0.3, p =
0.01). Elasticity and resting tension were higher in males compared to females (p = 0.001) and both correlated positively
with height (p = 0.01). Values above healthy population cut-off were observed in 16 patients (41 %) for neural
component, in 2 (5 %) for elastic component and in 23 (59 %) for viscous component. Neural component above
cut-off did not correspond well to MAS ratings. Ten patients with MAS = 0 had neural component values above cut-off
and five patients with MAS≥ 1 had neural component within normal range.
Conclusion: This study provides NeuroFlexor cut-off values that are useful for detection of spasticity in the early phase
after stroke.
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Background
Spasticity is one of the positive signs of the upper motor
neuron syndrome (UMNS) and is commonly defined ac-
cording to Lance as “a motor disorder characterized by a
velocity-dependent increase in tonic stretch reflexes with
exaggerated tendon jerks, resulting from hyperexcitabil-
ity of the stretch reflex” [1]. Spasticity occurs in a num-
ber of neurological conditions and may contribute to
impaired body functions and activity limitations after
stroke [2–4]. The prevalence of spasticity is 20–25 %
after first-ever stroke, as assessed with conventional clin-
ical evaluation methods such as the modified Ashworth
scale [3–7]. Spasticity development is highly variable be-
tween individuals even though poor sensorimotor func-
tion is an identified risk factor [8–10].
The most commonly used clinical scale of spasticity is
the modified Ashworth Scale (MAS) [11]. However, the
MAS is a subjective scale with limited validity and reli-
ability [12–14]. Another limitation is that the MAS does
not allow separate measurement of neural (reflex) and
non-neural (muscle and connective tissue) contributions
to resistance to passive stretch. Other clinical methods,
such as the REPAS [15] and the Tardieu scale [16] may
enhance the diagnostic accuracy but do not objectively
quantify spasticity. Thus, there is a generally recognized
need for new and easy to use methods that enable more
accurate and reliable evaluation of spasticity and which
can help optimize choice and timing of treatments [17].
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Spasticity may be managed by a wide variety of thera-
peutic interventions including physical therapy,
pharmacological agents and surgical treatment [4].
There is now consistent evidence that spasticity after
stroke can be significantly reduced by treatment with
intramuscular BoNT-A [18, 19]. However, this treat-
ment can be efficient when the increase in resistance to
passive movement is associated with a predominant
neural contribution while the stretching technique
would probably more effective if the resistance is pre-
dominantly elastic [20, 21].
A new instrument, the NeuroFlexor (Aggero MedTech
AB, Solna, Sweden) has recently been developed to quan-
tify the neural (spasticity) and non-neural (elasticity and
viscosity) components of the resisting force produced by
passive extension at the wrist. This method has been
shown to be valid, reliable and sensitive to change when
used to measure spasticity after stroke [22–24]. However
normative data from a large cohort of healthy subjects is
lacking. The primary aim of this study was to obtain
normative NeuroFlexor data from healthy subjects and to
describe the relation to anthropometric variables. The
second aim was to use the normative data to establish
NeuroFlexor cut-off values in order to explore early signs
of spasticity after stroke.
Methods
Participants
A total of 107 healthy adult subjects (55 females and 52
males; age range 20 to 68 years, mean 44.5 years) were
enrolled into a single control group. The subjects were re-
cruited from the employees and the students of Danderyd
University Hospital, Stockholm, Sweden. The participant’s
demographic characteristics are shown in Table 1. The ex-
clusion criteria were disorders of the hand (neurological
or rheumatologic conditions), fractures of upper limb in
the previous six months, presence of pacemaker or other
stimulators and pregnancy.
A sample of 39 stroke patients (13 females and 26
males; age range 33 to 69 years, mean 55.4 years), re-
cently admitted as inpatients to the department of
Rehabilitation Medicine (mean time post-stroke 2–4
weeks), was assessed with the NeuroFlexor. Clinical
description of patients is presented in Table 2. Inclu-
sion criterion was first ever stroke with clinical diag-
nosis of arm paresis (upper limb weakness on clinical
exam). Exclusion criteria were other disorders of the
hand (neurological or rheumatologic conditions) and
cerebellar lesions.
Ethical approval was obtained from the Regional eth-
ical review board in Stockholm, and written informed
consent was required of all participants in accordance
with the Declaration of Helsinki.
Study design
This was a cross-sectional study with a single test ses-
sion beginning with a health status questionnaire and
recording of anthropometric measurements: height,
body weight and hand size (approximated by the dis-
tance between wrist joint and the third metacarpal
heads). Passive range of motion of the wrist was measured
using a goniometer, with the subject seated with the elbow
in 90° of flexion and fingers extended. Maximal grip
strength was measured using the Jamar isometric dyna-
mometer [25]. The mean value from three attempts of the
dominant hand was recorded. Clinical assessment of
upper limb function in stroke patients also included the
modified Ashworth scale and the Fugl-Meyer assessment
of the upper extremity (FMA–UE) [26].
The NeuroFlexor (www.aggeromedtech.com; Fig. 1)
was used to quantify passive movement resistance dur-
ing wrist extension and to calculate the contributing
components. Measurements were performed on the
dominant hand in healthy subjects and on the impaired
hand in stroke patients.
NeuroFlexor variables and procedures
The NeuroFlexor method has been previously presented
and validated in other studies on spasticity after stroke
[22–24]. The biomechanical model allows separating the
passive movement resistance at the wrist into active
force produced by muscle contractions induced by
stretch reflexes and passive mechanical components: in-
ertia, resting tension, viscosity and elasticity (see exam-
ples in Fig. 2). The variables are briefly described below.
Resting Tension (P0)
Resting tension reflects the tonic muscle tension of the
hand before onset of stretch.
Inertia Component (IC)
Inertia is the force resisting the acceleration of the hand
and depends on the mass of the hand and the movable
platform and the acceleration (IC =m x a, where m is
the mass of hand and platform, and a is the acceler-
ation). In the model the mass of the hand was estimated
to be 0.6 % of body weight.
Elastic Component (EC)
Elasticity is a length-dependent resisting force that in-
creases as muscles and tendons are stretched. High EC
values thus reflect a reduced elasticity of stretched
tissues. In the model, EC was recorded 1 s after the end
of the passive slow movement (5°/s, P3; see example in
Fig. 2), thus minimizing possible contribution from
stretch reflexes.
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Table 1 Demographic characteristics of the healthy subjects.
Data are presented for the entire group (n= 107) and related to
age (range of age 20–29, n = 17; 30–39, n= 23; 40–49, n= 27;
50–59, n= 19; 60–70, n= 21)
Variables
Age, years
Mean (SD) 44.49 (13.99)








Mean (SD) 173.12 (9.44)
Min – Max 151 – 193
Body weight, kg
Mean (SD) 71.87 (12.85)
Min – Max 49 – 110
Hand size, mm
Mean (SD) 79.7 (7.66)
Min – Max 64 – 110
Total passive ROM, angle in degrees
Mean (SD) 165.37 (11.42)
Min – Max 135 – 180
Maximal grip strength, kg
Mean (SD) 42.43 (11.91)
Min – Max 19.2 – 70.9
Range of age
20 – 29








Mean (SD) 171.18 (8.03)
Body weight, kg
Mean (SD) 64.53 (7.87)
Hand size, mm
Mean (SD) 78.12 (5.47)
Total passive ROM, angle in degrees
Mean (SD) 170 (9.01)
Table 1 Demographic characteristics of the healthy subjects.
Data are presented for the entire group (n= 107) and related to
age (range of age 20–29, n = 17; 30–39, n= 23; 40–49, n= 27;
50–59, n= 19; 60–70, n= 21) (Continued)
Maximal grip strength, kg
Mean (SD) 38.46 (9.22)
30 – 39








Mean (SD) 175.04 (10.42)
Body weight, kg
Mean (SD) 71.09 (14.55)
Hand size, mm
Mean (SD) 80.22 (6.52)
Total passive ROM, angle in degrees
Mean (SD) 168.7 (11.4)
Maximal grip strength, kg
Mean (SD) 45.53 (12.57)
40 – 49








Mean (SD) 174.26 (8.95)
Body weight, kg
Mean (SD) 74.61 (14.92)
Hand size, mm
Mean (SD) 80.78 (9.26)
Total passive ROM, angle in degrees
Mean (SD) 162.22 (11.71)
Maximal grip strength, kg
Mean (SD) 45.36 (11.73)
50 – 59
Subjects, n (%) 19 (18)
Gender, n (%)
Male 9 (47)
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Viscous Component (VC)
The viscosity is the force produced by friction from
neighbouring tissues, for example sliding muscle fibres.
The viscosity depends on the velocity of the muscle
stretch and is highest during the initial acceleration and
continues at a lower level during the remaining muscle
stretch. In the model, the early viscosity component was
defined as the resisting force that remained after the
inertia component had been subtracted from the initial
peak of the total resisting force at P1 (VCP1 = Total for-
ceP1 – IC). The later viscosity had to be approximated;
there is a rather stable relationship between the early
and late viscosities described by Halaki et al. [27], in
which the late viscosity at P2 is about 20 % of the early
viscosity at P1 (VC = (Total forceP1 – IC) x 0.2). The late
viscosity, at the end of the movement, was taken as the
VC measure.
Neural Component (NC)
The muscle stretch can activate spinal stretch reflexes
with a latency of about 40 ms, followed by later
stretch evoked responses adding to the first muscle
contraction. In the model, the NC was estimated at
the maximal extension at the end of the passive
movement (P2) by subtracting the elasticity and vis-
cosity components from the total force. (NC = Total
forceP2 – (EC + VC))
In this study, the NeuroFlexor measurements were
performed according to the standardized procedure in
previous studies [22–24] The participants were seated
comfortably, with the elbow in 90° of flexion, the
forearm in pronation and the dominant hand placed
on the device platform. They were instructed to relax
during the testing session, which consisted of passive
extension of the wrist at two velocities, slow (5°/s)
and fast (236°/s). The total range of wrist movement
was 50°, between a starting angle of 20° of palmar
flexion to 30° of extension. For each participant, one
value of NC, EC and VC in Newton was calculated
by dedicated software using recordings from nine fast
and four slow passive movements. Resistance profiles
were also obtained when the device ran empty (with-
out hand; see resistance trace examples in Fig. 2) to
enable the biomechanical model to isolate forces ori-
ginating from the hand [22].
Statistical analysis
The data were analyzed using the Statistical Package for
the Social Sciences (SPSS). Descriptive statistics were
shown as mean, standard deviation (SD) and frequencies
(%). Cut-off scores for NC, EC, VC and resting tension
were obtained by adding 3 SD to the mean [28]. For
comparison, cut-off values were also calculated using
prediction reference limits (99 % confidence interval, CI)
obtained from linear regression of each component with
age. Small negative NC values may occur due to slight
differences in placement of the hand in relation to the
centre of the platform force sensor [22]. The healthy
population was divided by gender and into five age
groups (20–29, 30–39, 40–49, 50–59, 60–70 years old)
in order to obtain age and gender specific cut-off limits.
Parametric methods of analysis were applied since the
variables were not severely skewed (Skewness value for
NC = 0.45, EC = 0.07 and VC= 0.81). Pearson’s correlation
Table 1 Demographic characteristics of the healthy subjects.
Data are presented for the entire group (n= 107) and related to
age (range of age 20–29, n = 17; 30–39, n= 23; 40–49, n= 27;
50–59, n= 19; 60–70, n= 21) (Continued)
Female 10 (53)




Mean (SD) 175.95 (10.78)
Body weight, kg
Mean (SD) 73.63 (11.9)
Hand size, mm
Mean (SD) 81.26 (9.57)
Total passive ROM, angle in degrees
Mean (SD) 166.84 (8.86)
Maximal grip strength, kg
Mean (SD) 42.68 (11.43)
60 – 70








Mean (SD) 171.29 (8,91)
Body weight, kg
Mean (SD) 73.57 (10.66)
Hand size, mm
Mean (SD) 77.62 (5.98)
Total passive ROM, angle in degrees
Mean (SD) 160.71 (12.87)
Maximal grip strength, kg
Mean (SD) 38.51 (12.7)
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Table 2 Clinical description of stroke patients
NC = neural component, EC = elastic component, VC = viscous component, Passive ROM = passive range of motion, MAS =modified Ashworth scale, FMA-UE =
Fugl-Meyer assessment of the upper extremity. Pathological values of neural, elastic and viscous components in relation to cut-off values obtained by adding three
standard deviations to mean are marked (*). Grey areas highlight (i) stroke patients with NC higher than cut-off value (≥3.4 N) without clinical detection of
spasticity according to MAS and (ii) stroke patients with positive MAS scores but with NC within normal limits
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was used to test for relation between age, anthropometric
data and NeuroFlexor variables (r). One-way ANOVA was
used for studying differences related to gender. For
post-hoc analysis Fisher's least significant difference
(LSD) test was used.
In stroke patients, Spearman rank correlation was used
to test correlations between NeuroFlexor measurements
and the clinical scales scores (rs) since some data were
not normally distributed (Shapiro-Wilk’s test, p < 0.05
and skewed distribution). Mann–Whitney U test was
used to compare the NC, EC, VC and resting tension
values between stroke patients and healthy subjects. The
significance level was set at p ≤ 0.05.
Results
Normative data and cut-off values
NeuroFlexor recordings were similar across healthy
subjects leading to small variations in components
(Fig. 2). In the healthy group (n = 107) NC was 0.8 ±
0.9 N (mean ± SD), EC was 2.7 ± 1.1 N, VC was 0.3 ±
0.3 N and resting tension was 5.9 ± 1 N. Thus EC
was found to be the component contributing the
most to passive movement resistance in healthy sub-
jects. The cut-off value (according to mean + 3SD)
established for NC was 3.4 N, for EC was 6 N, for
VC was 1.1 N and for the resting tension was 9 N.
Less conservative prediction reference limits were ob-
tained from 99 % CI limits of the linear regression re-
lated to age and also separately by gender, as shown
in Table 3 and 4.
Relation to age and anthropometric data
In healthy subjects, a significant correlation was found be-
tween height and EC (r = 0.31, p = 0.01), and height and
resting tension (r = 0.37, p = 0.01). Thus, taller subjects
had higher EC and P0 values. Body weight also correlated
positively with resting tension (r = 0.42, p = 0.01). Hand
size did not correlate with any NeuroFlexor variables. Age
did not correlate significantly with NC (r = 0.08) or with
VC (r = 0.2) but did correlate negatively with EC (r = −0.3,
p = 0.01). EC was thus lower in older compared to youn-
ger subjects. There was not found a significant correlation
between age and height (r = 0.021). There were no gender
differences for NC or VC. However, EC and resting
tension were higher in males compared to females (F = 12,
p = 0.001 and F = 12.8, p = 0.001, respectively). Total
passive ROM (mean 165° ± 11°) did not relate to age and
was similar in males and females.
Use of cut-off values for early detection of spasticity
Individual NeuroFlexor recordings showed increased re-
sistance profiles during passive stretch of the affected
hand in some stroke patients (examples shown in Fig. 2).
In the stroke group (n = 39) NC was 4.8 ± 8.1 N (mean ±
SD), EC was 3.7 ± 1.4 N, VC was 1.4 ± 0.6 N and resting
tension was 5.3 ± 1.5 N. Thus NC was the component
contributing the most to the passive movement resist-
ance in stroke patients. Mann–Whitney U test indicated
that stroke patients had higher NC, EC and VC com-
pared to the control group (U = 1487.5, p = 0.008; U =
1258.5, p = 0.000; U = 128.5, p = 0.000, respectively). P0
Fig. 1 NeuroFlexor measurement device. The NeuroFlexor instrument showing the position of the hand with the metacarpophalangeal joints in
slight flexion and the fingers completely extrended, and with the wrist axis of rotation aligned with the device. The instrument passively extends
the wrist joint in a 50° range of motion with a starting angle of 20° of palmar flexion, and the movement is performed at controlled slow and fast
velocities (5 and 236°/s, respectively)
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was statistically significantly higher in healthy subjects
than in stroke patients (U = 1455, p = 0.005). According
to mean + 3SD cut-off values, some stroke patients
showed pathologically high NC, EC and VC values (illus-
trated in Table 2 and in Fig. 3). Resting tension was
above cut-off in only one patient (Patient 19), showing
that both healthy subjects and patients were equally
relaxed at the beginning of the stretch. Sixteen stroke
patients had NC values at or above the cut-off value of
3.4 N (mean + 3SD). Two patients showed EC values
above cut-off (>6 N) and 23 patients had VC values
above cut-off (>1.1 N). The age and gender specific
Fig. 2 NeuroFlexor force traces. Example resistance profiles (N, newton) during slow and fast velocity movements in a young and old healthy
subject and in two stroke patients. Blue traces show the angle of wrist movement (from flexion to extension). Red traces show mean resisting
force from repeat trials and black traces shows mean resistance profiles when device runs without hand. Four time points are automatically
identified by the software: P3 1 s after slow passive stretch; P0 in the beginning of the fast movement, P1 the first peak and P2 the peak towards
the end of the fast movement. Values of neural (NC), elastic (EC) and viscous components (VC) are shown for each participant. Both healthy
subjects show similar force profiles and have similar NC, EC, and VC components despite differences in age. In the patient examples the force
increased during the fast movements (P2). While both patients presented NC values above normative cut-off (>3.4 N), only Patient 5 had a positive
MAS score (see Table 2)
Pennati et al. Journal of NeuroEngineering and Rehabilitation  (2016) 13:30 Page 7 of 11
linear regression analysis for EC gave the same result,
with two patients above cut-off.
Relation to clinical measures
In the stroke group, total passive ROM (mean 153° ± 14°)
was statistically significantly different from pROM values
measured in the healthy subjects (U = 977, p = 0.000).
Clinical MAS ratings did not correspond well with patho-
logical NC (values > cut-off). NC was above cut-off in ten
patients without signs of spasticity according to MAS (i.e.,
MAS = 0, Table 2). MAS scores were >0 in certain patients
(n = 5) that had NC within normal range. For example, Pa-
tient 13, 26, 31, 32, and 33 had MAS > 0 in finger and/or
wrist flexors but had NC values < 3.4 N (Table 2). Of the
NeuroFlexor variables only NC correlated with upper limb
function as measured with the FMA–UE (rs = −0.38, p =
0.05). NC also correlated negatively with total passive
ROM in patients (rs = −0.38, p = 0.05). Thus patients with
high NC values had lower FMA–UE scores and lower
total passive ROM at the wrist.
Discussion
The present study provided normative NeuroFlexor data
from a large cohort of healthy subjects. This data
allowed a detailed description of how age, gender and
anthropometric measurements relate to NeuroFlexor
components. Healthy population-based cut-off values
proved useful for detection of pathologically high neural
and non-neural components of the resisting force pro-
duced during passive wrist extension in stroke patients.
These results are promising for the early clinical detec-
tion of spasticity after stroke.
Normative data and cut-off values
The cut-off values obtained using two different
methods showed some minor differences (Table 3 and
4). For the NC, the mean + 3SD approach resulted in
a slightly more conservative cut-off value (3.4 N)
while the linear regression cut-offs varied little across
age groups. This was expected since no relation
between NC and age was found. The absence of cor-
relation with age is in accordance with previous
neurophysiological studies which did not find de-
creased motoneuronal excitability or changes in tonic
stretch reflex with aging [29–31]. VC cut-off values
were also similar with the two approaches and again
no effect of age was found. In contrast, small differ-
ences were found in EC and resting tension cut-offs.
This was in line with the relation of these two vari-
ables to age and gender. EC/height ratio was similar
between gender (0.023 for the males and 0.017 for fe-
males) and this suggests that the gender effect is
likely explained by greater muscle mass in males
compared to females. The reason for the reduction of
EC with age was less clear, given that age is associ-
ated with increasing muscle stiffness [32–34]. How-
ever, aging also leads to reduced muscle mass and
increased fat deposits [35]. A decreased proportion
of muscle to adipose tissue in the forearm should
lead to a reduced EC and could thus explain our
findings. Indeed, our findings are in accordance with
previous reports of reduced passive resistance with
age [36].
In future research or clinical use, we recommend to
use the slightly more conservative mean + 3SD cut-off
when investigating NC and VC and the age and gender
specific cut-offs when investigating EC and resting
tension. This approach should limit false positives in
detection of pathological values.
Use of cut-off values for early detection of spasticity
EC contributed the most to passive movement resistance
in healthy subjects while the passive resistance in stroke
patients was predominantly neural in origin. This is in
line with data presented in previous studies showing that
NC is often increased after stroke, reflecting stretch
reflex hyperexcitability [22, 37–39].
Sixteen patients (41 %) had pathologically high NC at
2–4 weeks after first-ever stroke. A positive score of
Table 3 Cut-off values for measurement with NeuroFlexor
instrument obtained by adding three standard deviations to
mean (N, newton)
Mean Std. Deviation Min – Max Cut-off
NC 0.80 0.87 −0.99 – 3.02 3.4
EC 2.66 1.11 −0.41 – 5.66 6
VC 0.28 0.27 −0.25 – 1.26 1.1
Resting tension 5.88 1.03 2.71 – 8.46 9
NC neural component; EC elastic component; VC viscous component
Table 4 Prediction reference limits for measurement with
NeuroFlexor instrument obtained from a linear regression
analysis (99 % CI) related to age and gender (N, newton)
30 years 40 years 50 years 60 years 70 years
NC 3.0 3.0 3.1 3.2 3.3
EC
All population 5.8 5.6 5.3 5.1 4.9
Male 6.6 6.2 5.8 5.4 5.1
Female 4.8 4.7 4.7 4.6 4.5
VC 0.91 1.0 1.0 1.0 1.1
Resting tension
All population 8.2 8.5 8.6 8.8 9.0
Male 8.8 8.9 9.0 9.1 9.3
Female 7.6 7.9 8.1 8.4 8.7
NC neural component; EC elastic component; VC viscous component
Pennati et al. Journal of NeuroEngineering and Rehabilitation  (2016) 13:30 Page 8 of 11
MAS occurred in 11 out of 39 patients (28 %) and only
6 of these had NC above cut-off values. MAS still re-
mains the most common clinical assessment of spasticity
even if there is an increasing number of studies ques-
tioning its validity and reliability [12, 13, 40]. The limita-
tions of the MAS likely explain the poor correspondence
with the quantitative NC measures in this study. Both
false positives (patients with MAS > 0 with NC < cut-off )
and false negatives (patients with MAS = 0 with NC >
cut-off ) occurred. The joint angular velocity may
affect the perceived resistance in Ashworth assess-
ment as reported in literature [13, 41] while the
speed in NF measurement is constant and high
(236°/s) to be able to elicit the stretch reflex. Our
findings suggest that errors in MAS ratings can be
either positive or negative. It is moreover important
to consider that MAS is better suited for estimation
of spasticity in patients with moderate to severe
muscle tone and in later phase after stroke since the
MAS ratings correspond better to objective measure-
ments in the chronic phase after stroke [22]. Other
studies have also shown similar discrepancies with
MAS measurements when using quantitative biomechan-
ical approaches to measure spasticity [12]. The cut-off
values also allowed detection of pathological non–neural
components. EC was higher than the established cut-off in
two patients and VC was above in 23 patients. Although
pathologically high VC was detected in many patients the
absolute values were low (Fig. 3). The VC changes may
represent development of fibrosis and changes in the
extracellular muscle matrix [42].
The occurrence of spasticity in this study was higher
than reported in previous studies. Sommerfeld et al. [3]
reported that 20 % of the patients exhibited spasticity in
the upper extremity within 1 week and 18 % after
3 months; Wissel et al. [43] reported a prevalence of any
spasticity of 25 % within 1 week, 27 % at 6 weeks and
22 % at 6 months; Lundström et al. [7] 17 % after
12 months and Welmer et al. [44] 19 % in the first 1–2
weeks and 20 % at 18 months after stroke. In all of the
above mentioned studies, spasticity was defined as 1
point or more on the MAS. Watkins et al. [45] reported
a considerably higher prevalence of any spasticity (38 %)
according to both MAS and the Tone Assessment Scale,
while spasticity measured using only MAS was present
in 27 % of the patients. The discrepancy in the preva-
lence estimate between this study and the literature
might be related to the age of the patients (younger in
Fig. 3 Scatter plots NeuroFlexor variables. Scatter plots of neural (NC), elastic (EC) and viscous components (VC) and resting tension (P0), (N, newton)
in healthy population (circles) and stroke patients (triangles). Note the increased NC above cut-off in many stroke patients
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this study) as some evidence suggests that younger sub-
jects develop more spasticity than older subjects [10, 44].
Furthermore, it is important to consider that patients in
this study (inpatients in Department of Rehabilitation
Medicine) probably presented more severe stroke than did
the patients in other studies of unselected samples.
Study limitations
This study had some limitations. Firstly, this study did
not include a representative sample of all stroke patients
but a sample of patients admitted to a department of
Rehabilitation Medicine and this may explain the high
prevalence of spasticity. Thus caution should be taken
when comparing the observed prevalence of spasticity with
prevalence data from other studies. Secondly, a small num-
ber of stroke patients was included. However, the results
showed that the cut-off values from the larger healthy sub-
ject group were valuable in detecting abnormally high
values in the neural and non-neural components measured
with the NeuroFlexor.
Conclusion
This study provides NeuroFlexor reference data from a
healthy population and describes relationships with age,
gender and anthropometric variables. The reference data
allowed defining cut-off values that made it possible to de-
tect spasticity in the early phase of recovery after stroke.
The cut-off values are also promising for the detection of
non-neural changes in viscosity and elasticity of stretched
muscle in patients. Further studies are needed to investi-
gate the importance of the NeuroFlexor components for
the development of muscle contracture and for the sensori-
motor recovery of upper limb function after stroke [46].
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